Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Fatigue, Headache, Immunisation, Pyrexia
Clinical narrative: low grade fever (99.8 degrees F); headaches; sinus congestion; fatigue; diagnosed with secondary sinus infection; Dose received: 3; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 18Oct2021 10:30 (Lot number: FH8020) at the age of 69 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Penicillin allergy" (unspecified if ongoing); "Sulfa allergy" (unspecified if ongoing); "Hypertension" (ongoing); "Hypothyroidism" (ongoing); "Glaucoma" (ongoing); "Vitamin D3 insufficiency" (ongoing); "environmental allergies" (ongoing); "depression" (ongoing); "coronary calcification" (ongoing); "COVID-19", start date: 12Sep2020 (unspecified if ongoing); "frequent UTIs" (unspecified if ongoing); "spinal fusion L4-L5" (unspecified if ongoing); "osteoporosis" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN; BENAZEPRIL/HCTZ; METOPROLOL; INFLUENZA VACCINE taken for influenza immunisation. Past drug history included: Erythromycin, reaction(s): "allergies"; Flagyl, reaction(s): "allergies"; Ciprofloxacin, reaction(s): "allergies". Vaccination history included: Bnt162b2 (dose 2, lot number: EP6955,, at 12:00 PM, in the left arm), administration date: 29Mar2021, when the patient was 68 years old, for COVID-19 immunization, reaction(s): "Fever", "headache", "body aches"; Bnt162b2 (dose 1, lot number: EN6206,, at 12:00 PM, in left arm), administration date: 05Mar2021, when the patient was 68 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 18Oct2021 10:30, outcome "unknown", described as "Dose received: 3"; HEADACHE (non-serious) with onset 11Nov2021 18:00, outcome "recovering", described as "headaches"; SINUS CONGESTION (non-serious) with onset 11Nov2021 18:00, outcome "recovering", described as "sinus congestion"; FATIGUE (non-serious) with onset 11Nov2021 18:00, outcome "recovering", described as "fatigue"; SINUSITIS (non-serious) with onset Nov2021, outcome "recovering", described as "diagnosed with secondary sinus infection"; PYREXIA (non-serious) with onset 15Nov2021, outcome "recovered" (16Nov2021), described as "low grade fever (99.8 degrees F)". The events "headaches", "sinus congestion", "fatigue", "diagnosed with secondary sinus infection" and "low grade fever (99.8 degrees f)" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of sinusitis.  Additional information: during the week of 08Nov2021 through 11Nov2021, patient was caring for her sick granddaughter. On the date of this report, 18Nov2021, the headaches, sinus congestion, and fatigue were improving, but not totally resolved. Patient was seen at urgent care on 18Nov2021. Patient was also diagnosed with a secondary sinus infection for which she was prescribed doxycycline hyclate 100 mg capsules, twice daily for 10 days.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101619109 Same reporter/RA, Different dose/AE;US-PFIZER INC-202101618482 Same reporter/RA, Different dose (2nd)/AE